DEBBRAH – LMC Cohort
Phase II DEBBRAH: Trastuzumab Deruxtecan in Cohort With HER2+/HER-Low ABC and Leptomeningeal Carcinomatosis

Released: December 09, 2023

Activity

Progress
1
Course Completed